Dr. Trow received his A.B. degree from Bowdoin College graduating summa cum laude and Phi Beta Kappa with highest honors in Biochemistry in 1982. He subsequently matriculated at Dartmouth Medical School, earning his MD in 1986 after being elected to the Alpha Omega Alpha Society. After a year of internship at the Hospital of the University of Pennsylvania in Philadelphia he completed his internal medicine training at The New York Hospital of the Cornell University Medical College in 1989. After a brief period as a junior faculty member at Columbia College of Physicians and Surgeons in the Emergency Medicine Division, he pursued his fellowship training at Yale University in the Section of Pulmonary and Critical Care finishing in 1993. After 9 years of service at Danbury Hospital, where he was an integral member of the house staff teaching core faculty, he was recruited to establish and build the Pulmonary Hypertension Center at Winthrop-University Hospital in Mineola, NY, an affiliate of the State University of New York at Stony Brook from 2002-2005 before being recruited to due the same at Yale University School of Medicine where he currently holds the title of Director of the Pulmonary Vascular Disease Program as well as Associate Professor of Medicine.
Dr. Trow has won a number of teaching awards including Attending of the Year at Danbury Hospital as well as Attending of the Year at Winthrop-University Hospital and has been appointed Fellow of the American College of Physicians and the American College of Chest Physicians. He served as a Deputy Editor of The Proceedings of the American Thoracic Society and served on the editorial board of Clinical Pulmonary Medicine. He is an invited reviewer for such journals as Annals of Internal Medicine, Chest, the American Journal of Respiratory and Critical Care Medicine, Heart & Lung, Southern Medical Journal, Clinical Pulmonary Medicine, and the Annals of the American Thoracic Society, Drug Design, Development and Therapy,Respiratory Medicine and Thorax. Dr. Trow also served on the Steering Committee for the Pulmonary Vascular Disease Network for the American College of Chest Physicians from 2006-2013, as well as on the Steering Committee for the Scleroderma Foundation’s National Echocardiography Education Campaign. He was recently appointed to the Scientific Leadership Council of the Pulmonary Hypertension Association and was appointed to the ACCP Task force to update the ACCP Evidence-Based Guidelines in the Pharmcologic Therapy of Pulmonary Arterial Hypertension.
Dr. Trow’s research interests are in the arena of clinical biomarkers in pulmonary hypertension. He has published widely in such journals as Chest, the Proceedings of the American Thoracic Society, Clinical Pulmonary Medicine, the Journal of Biological Chemistry, Heart&Lung: The Journal of Acute Critical Care, the Journal of Immunology, the American Journal of Physiology, the American Journal of Medicine ,Clinic in Chest Medicine, Vascular Health and Risk Management, Therapeutic Advances in Respiratory Disease, Respiratory Medicine and Thorax.
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!